Acquisition of the Olink® Target 48 Immune Surveillance Panel

Firalis Molecular Precision announces the acquisition of the new Olink® Target 48 Immune Surveillance panel, which will enable our experts to screen 44 immune biomarkers in only 1 µl of sample.